OpGen (LTS:0A8L) 5-Year EBITDA Growth Rate : 64.60% (As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

What is OpGen 5-Year EBITDA Growth Rate?

OpGen's EBITDA per Share for the three months ended in Sep. 2023 was $-3.78.

During the past 3 years, the average EBITDA Per Share Growth Rate was 54.60% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 64.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 10 years, the highest 3-Year average EBITDA Per Share Growth Rate of OpGen was 79.00% per year. The lowest was 54.60% per year. And the median was 71.20% per year.

Competitive Comparison of OpGen's 5-Year EBITDA Growth Rate

For the Medical Devices subindustry, OpGen's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OpGen's 5-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, OpGen's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where OpGen's 5-Year EBITDA Growth Rate falls into.

OpGen 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

OpGen (LTS:0A8L) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

OpGen 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of OpGen's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

OpGen (LTS:0A8L) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » OpGen Inc (LTS:0A8L) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

OPGN:USA 650:Germany

Address

9717 Key West Avenue, Suite 100, Rockville, MD, USA, 20850

Website

https://www.opgen.com

OpGen Inc is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. It is developing molecular information products and services for healthcare settings, helping to guide clinicians with rapid and actionable information about life-threatening infections, improve patient outcomes, and decrease the spread of infections caused by MDROs. Its proprietary DNA tests and informatics address the rising threat of antibiotic resistance by helping physicians and other healthcare providers optimize care decisions for patients with acute infections. The company's product candidates and services combine its Acuitas molecular diagnostics and Acuitas Lighthouse informatics platform for use with its curated MDRO knowledge base.

OpGen (LTS:0A8L) Headlines

No Headlines